Weight

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care

These three disorders could really be “CKM syndrome,” which can be treated with drugs like Ozempic

Skipping meals before a big holiday feast probably isn’t the best idea for gut health, experts say. Here’s how to prevent overeating on an empty stomach—and tips for if you do

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight into potential new addiction therapies

Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others

While bariatric surgery can result in significant weight loss, weight stigma can persist years after the surgery.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes

A sleep medicine specialist explains how restless nights lead to consuming more calories and how you can use sleep as a tool for weight loss

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?

Intermittent fasting has gained a following, in part because of tantalizing hints that it can boost cognition, fend off cancer and even slow aging